You have 9 free searches left this month | for more free features.

Preleukemia

Showing 26 - 50 of 1,392

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Jul 30, 2023

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

Recruiting
  • Myelodysplastic Syndromes
  • +5 more
  • description of MDS pzatient cohort
  • Brest, France
    Chu Brest
Oct 27, 2022

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

Completed
  • Myelodysplastic Syndrome
  • SyB C-1101
  • Nagoya, Aichi, Japan
  • +3 more
Nov 14, 2022

Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Sep 18, 2023

MDS Trial (Hetrombopag)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
May 23, 2022

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

Refine and Assess Readability of Patient, Carer, and Clinician

Completed
  • Myelodysplastic Syndrome (MDS)
  • Carer Treatment Preference Myelodysplasia Questionnaire
  • +2 more
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
Apr 4, 2023

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Interplay Between Immune and Metabolic Programs in

    Recruiting
    • Myelodysplastic Syndromes
      • Toulouse, France
        IUCT-Oncopole University Hospital
      May 17, 2022

      Acute Myeloid Leukemia and Myelodysplastic Syndrome Trial in Tianjin (QLF32101)

      Not yet recruiting
      • Acute Myeloid Leukemia and Myelodysplastic Syndrome
      • Tianjin, Tianjin, China
        Institute of Hematology&Blood Diseases Hospital,Chinese Academy
      Jan 27, 2023

      Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)

      Withdrawn
      • Myelodysplastic Syndrome
      • SyB C-1101 and Azacytidine
      • Nagoya, Aichi, Japan
      • +3 more
      Nov 14, 2022

      Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome With Excess Blasts-2
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jan 26, 2023

      Physical Activity in Transfusion Dependent Myelodysplastic

      Recruiting
      • Myelodysplastic Syndromes
      • Medical Device Usage and Evaluation
      • +3 more
      • Philadelphia, Pennsylvania
        Sidney Kimmel Cancer Center at Thomas Jefferson University
      Aug 16, 2022

      Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

      Active, not recruiting
      • Acute Myelogenous Leukemia
      • Myelodysplastic Syndrome
      • Gemtuzumab Ozogamicin
      • Valhalla, New York
        New York Medical College
      Sep 26, 2022

      Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

      Completed
      • Acute Myelogenous Leukemia (AML)
      • Myelodysplastic Syndrome (MDS)
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Jan 4, 2023

      MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

      Recruiting
      • Myelodysplastic Syndromes
      • Canakinumab Injection
      • Darbepoetin Alfa
      • Tampa, Florida
        Moffitt Cancer Center
      Nov 21, 2022

      Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

      Active, not recruiting
      • Leukemia
      • +7 more
      • Boston, Massachusetts
      • +10 more
      Jan 19, 2023

      Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

      Recruiting
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +2 more
      • VEN+AZA+Modified BUCY
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Apr 10, 2023

      Myelodysplastic Syndrome (MDS) Trial in Yamagata (ASTX030)

      Recruiting
      • Myelodysplastic Syndrome (MDS)
      • Yamagata, Japan
        Yamagata University Hospital
      Jun 20, 2022

      Minimisation Measures for REBLOZYL Among Healthcare

      Active, not recruiting
      • Myelodysplastic Syndromes
      • Beta-thalassemia
        • City, State, Austria
          Local Institution
        Aug 4, 2022

        MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • Acute Myeloid Leukemia
        • (no location specified)
        Sep 2, 2022

        Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

        Not yet recruiting
        • Higher Risk Myelodysplastic Syndrome
        • Chronic Myelomonocytic Leukemia
        • (no location specified)
        Jul 29, 2022

        Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Myelodysplastic Syndromes
        • Rochester, Minnesota
        • +1 more
        Feb 15, 2023